Breaking News
April 23, 2019 - Neuroscientists propose new theory about amyloid precursor protein connection in Alzheimer’s
April 23, 2019 - Mediterranean diet protects against overeating and obesity
April 23, 2019 - NUS scientists uncover novel biomarkers linked with ‘chemobrain’
April 23, 2019 - Novel ECCITE-seq technique expands multimodal single cell analysis
April 23, 2019 - Half of all American workplaces offer health and wellness programs
April 23, 2019 - Perinatal Complications Tied to Childhood Social Anxiety
April 23, 2019 - Research reveals how immune cells help tumors escape body’s defenses
April 23, 2019 - UAB receives $17 million grant to explore immune cells in inaccessible tissues of the human body
April 23, 2019 - Opening blocked arteries may be lifesaver for older heart attack patients
April 23, 2019 - Yposkesi chairman to speak on ‘Manufacturing and the CDMO Perspective’ at Cell and Gene Meeting
April 23, 2019 - Listeria Outbreak Linked to Deli Meats, Cheeses in 4 States
April 23, 2019 - Scientists find another way HIV can hide from vaccines
April 23, 2019 - EU ban on ‘meaty’ names for veggie food products would affect public sector
April 23, 2019 - KNAUER self-tests gender pay gap one month after Equal Pay Day
April 23, 2019 - Johns Hopkins study reports overdiagnosis of schizophrenia
April 23, 2019 - New approach to repair defects in fetal membranes could prevent life-long medical conditions
April 23, 2019 - Reviving the heart’s regenerative capacities using microRNAs
April 23, 2019 - New pediatric blood pressure guidelines can better predict kids at higher risk of heart disease
April 23, 2019 - Second HIV remission patient rekindles cure hope
April 23, 2019 - Sparse Treatment Options Complicate Cancer Care For Immigrants In South Texas
April 23, 2019 - Hole-forming protein could help control cancer growth
April 23, 2019 - Study examines factors associated with low use of hearing aids among older Hispanic/Latino adults
April 23, 2019 - Changes to Medicare rules could support care innovation for dialysis
April 23, 2019 - Cancer patients requiring emergency department care have better outcomes at original hospital
April 23, 2019 - Potential of liquid biopsy in cancer biomarker detection and prenatal testing
April 23, 2019 - Researchers identify circulating proteins associated with progression of diabetic kidney disease
April 23, 2019 - Microglia play vital role in regulating neuroinflammation, research shows
April 23, 2019 - Pfizer and Lilly Announce Top-Line Results From Long-Term Phase 3 Study of Tanezumab in Patients With Osteoarthritis
April 23, 2019 - One-month regimen noninferior for preventing HIV-related TB
April 23, 2019 - Educational program for preschoolers successful in instilling heart healthy behaviors
April 23, 2019 - Asia’s diabetes epidemic increases risk of death among women, middle-aged people
April 23, 2019 - First-of-its-kind study highlights lethal impact of medical emergencies worldwide
April 23, 2019 - Workshop explores the future of artificial intelligence in medical imaging
April 23, 2019 - Research shows mindful body awareness training helps women recover from drug addiction
April 23, 2019 - Researchers are developing brand-new method to cure brain tumors
April 23, 2019 - Torrent Pharmaceuticals Limited Expands Voluntary Nationwide Recall of Losartan Potassium Tablets, USP and Losartan Potassium/Hydrochlorothiazide Tablets, USP
April 23, 2019 - First case of person without the protein needed to transport vitamin D identified
April 23, 2019 - Precision-guided anticancer nanoparticles help enhance treatment of peritoneal tumors
April 23, 2019 - Smoking cessation during pregnancy associated with reduced risk of preterm birth
April 23, 2019 - Researchers discover why women get autoimmune diseases far more often than men
April 23, 2019 - New Medicare reimbursement rules provide some relief to safety-net hospitals
April 23, 2019 - Sensory Sensitivity Tied to Constipation in Young Children
April 23, 2019 - More than half of internal medicine graduates choosing primary care
April 22, 2019 - Researchers discover good news for fish populations living on bleached coral reefs
April 22, 2019 - Plant-based diets associated with lower risk of heart failure
April 22, 2019 - Food Allergies Can Strike at Any Age
April 22, 2019 - Cerebro-facio-thoracic dysplasia – Genetics Home Reference
April 22, 2019 - Poverty leaves a mark on our genes
April 22, 2019 - Countdown to Big Data in Precision Health: When industry and academia converge
April 22, 2019 - The U.S government may account for up to $37.8 billion due to opioid epidemic
April 22, 2019 - Improving ACA’s Insurance Coverage Provisions will lead to better care for patients
April 22, 2019 - Study identifies possible therapeutic effects of curcumin on stomach cancer
April 22, 2019 - Hyaline fibromatosis syndrome – Genetics Home Reference
April 22, 2019 - Scientists use CRISPR for possible ‘bubble boy’ therapy
April 22, 2019 - Hematologist (and a mom, singer, actress and much more) stands up for diversity
April 22, 2019 - Novel AI voice tool can help diagnose PTSD
April 22, 2019 - Physical activity may eliminate mortality risk caused by sedentary behavior
April 22, 2019 - Overlooked part of cell’s internal machinery may hold key to treating acute myeloid leukemia
April 22, 2019 - Nursing, medical, and dental students train together to improve pediatric oral health
April 22, 2019 - Soft bedding responsible for majority of sleep-related infant deaths, study reveals
April 22, 2019 - Study finds worse health-related quality of life among transgender adults
April 22, 2019 - MIT scientists reverse some behavioral symptoms of rare neurodevelopmental disorder
April 22, 2019 - Scientists find new therapy target for drug-induced liver failure
April 22, 2019 - Opioid dose variability could lead to increased risk of overdose, study suggests
April 22, 2019 - Newly developed model predicts salmonella outbreaks several months in advance
April 22, 2019 - Deep-learning model better predicts survival outcomes for lung cancer
April 22, 2019 - One in Three U.S. Adults Aged 35 to 44 May Have Drinking Problem
April 22, 2019 - Why the measles virus is so contagious
April 22, 2019 - Magnet ‘Zap’ to the Brain Might Jumpstart Aging Memory
April 22, 2019 - Immune response to gut microbes may be early indicator of type 1 diabetes
April 22, 2019 - Destination Limbo: Health Suffers Among Asylum Seekers In Crowded Border Shelter
April 22, 2019 - Research shows how dopamine contributes to sex differences in worms
April 22, 2019 - Marijuana users weigh less compared to non-users
April 22, 2019 - Research uncovers critical RNA processing aberrations in ALS and FTD
April 22, 2019 - Many cancer patients use marijuana and prescription opioids, study reveals
April 22, 2019 - Frailty may up fracture risk in patients with type 2 diabetes
April 22, 2019 - Study provides new insight into how obesity, insulin resistance can affect cognition
April 22, 2019 - Study seeks to better understand the genetic causes for hypospadias
April 22, 2019 - FDA grants approval of first generic naloxone nasal spray to treat opioid overdose
April 22, 2019 - FDA authorizes marketing of first medical device to treat ADHD
UMGCCC uses Gammapod radiotherapy to treat breast cancer patients

UMGCCC uses Gammapod radiotherapy to treat breast cancer patients

image_pdfDownload PDFimage_print

Novel device aims to shorten treatment, possibly eliminate surgery for early-stage breast cancer

Radiation oncologists at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) are now treating patients with the GammaPod™, a new FDA-cleared radiation therapy for early-stage breast cancer. The UMGCCC is the first site to treat patients with this first-of-its-kind system, which was invented by University of Maryland School of Medicine (UMSOM) scientists and physicians. This is the only external-beam radiation delivery system specifically designed to treat breast cancer.

“With this new technology, we are able to significantly shorten the length of radiation treatment for early breast cancer – from up to six weeks, to only a matter of days,” says Elizabeth M. Nichols, MD, an assistant professor of radiation oncology and clinical director of the Department of Radiation Oncology at UMSOM.

“Not only is this approach more convenient for patients, but it can also potentially reduce side effects, such as skin reactions, which can result from traditional radiation therapy,” says Dr. Nichols, who treats patients at UMGCCC. “We expect that GammaPod’s highly focused radiation will also help to improve cosmetic outcomes for our patients.”

Granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) in December 2017, the GammaPod stereotactic radiation therapy system delivers a high dose of radiation to a specific area in the breast, sparing nearby healthy tissue and major organs such as the heart and lungs.

Typically, patients with early-stage breast cancer have surgery to remove a tumor, followed by three to six weeks of standard radiation therapy to the whole breast to help kill residual cancer cells and prevent recurrence. Stereotactic radiation therapy is most commonly used to treat brain cancer and cancers in other parts of the body; the GammaPod enables this high-precision technology to be used for breast cancer, to target part of the breast.

“GammaPod allows us to optimize the use of stereotactic radiosurgery to treat breast cancer,” says co-inventor William F. Regine, MD, FACR, FACRO, the Isadore & Fannie Schneider Foxman Endowed Chair and professor of radiation oncology at UMSOM and chief of radiation oncology at UMGCCC.

Patients with early-stage cancer who are eligible to receive “partial breast irradiation” with the GammaPod will receive five days of treatment to the tumor site after surgery in a noninvasive fashion. These are primarily women with small tumors whose cancer has not spread to the lymph nodes.

The GammaPod can also be used to provide a single “boost” treatment to women with breast cancer of any stage, including more advanced cancers, instead of four to five treatments, thereby shortening the overall duration of radiation therapy. This treatment would be in addition to standard radiation therapy to the whole breast.

UMGCCC doctors also expect to soon begin treating early-stage patients with the GammaPod before surgery, to gauge the machine’s effectiveness in reducing the size of a tumor or destroying the cancer altogether.

“The promise and hope of the GammaPod is that we will be able to change the paradigm for treating early-stage breast cancer by identifying patients who can be treated with radiation alone, potentially eliminating the need for surgery,” says Dr. Nichols, who is leading a research consortium with other sites that will have the GammaPod system within the year.

“Increasingly, the focus is on developing strategies to reduce treatment for low-risk breast cancer patients, and the GammaPod is in line with these efforts,” she says.

Patients who are treated with the GammaPod will be enrolled in clinical trials so that investigators can collect data to evaluate the new treatment system. Additional studies are planned.

“We envision that one day we’ll be able to neutralize a tumor with a high dose of focused radiation instead of removing it with a scalpel,” says inventor Cedric X. Yu, DSc, FAAPM, the Carl Mansfield, MD Professor in Radiation Oncology at UMSOM and the founder and chief executive officer of Xcision Medical Systems, LLC. “This approach would spare patients the negative side effects of surgery and prolonged radiation treatments, significantly improving their quality of life.”

In developing the system, Dr. Yu sought to create a noninvasive alternative to brachytherapy, a common type of partial breast irradiation in which doctors insert radioactive sources through catheters, or tubes, into the breast to deliver high-dose radiation to the area where the tumor was removed.

The GammaPod system targets a tumor with thousands of precisely focused beams of radiation from 25 rotating sources. A patient is treated lying on her stomach with her breast immobilized by a patented vacuum-assisted cup. The couch moves during treatment as radiation “paints” the tumor. Treatments take five minutes to 40 minutes, depending on the therapy plan.

The machine gets its name from the type of radiation (gamma rays) and the pod-like shape of the machine.

“We are incredibly proud that after more than a decade of research and development, this novel radiation therapy system invented by two of our faculty members will now help shorten treatment times for women with early-stage breast cancer,” says UMSOM Dean E. Albert Reece, MD, PhD, MBA, University Executive Vice President for Medical Affairs and the John Z. and Akiko K. Bowers Distinguished Professor. “I congratulate Dr. Regine and Dr. Yu on this tremendous achievement.”

Source:

https://www.umms.org/umgccc/news/2018/gammapod-launch

Tagged with:

About author

Related Articles